Screener
BridgeBio Pharma BBIO Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's gross profit?
- BridgeBio Pharma (BBIO) reported gross profit of $184.58M in Q1 2026.
- How has BridgeBio Pharma's gross profit changed year-over-year?
- BridgeBio Pharma's gross profit increased by 61.9% year-over-year, from $113.99M to $184.58M.
- What is the long-term trend for BridgeBio Pharma's gross profit?
- Over 4 years (2021 to 2025), BridgeBio Pharma's gross profit has grown at a 63.7% compound annual growth rate (CAGR), from $66.98M to $481.11M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about BridgeBio Pharma's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude